Medivolve Inc (MEDV.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 51 | 52 | 51 | 139 | 159 |
| Accounts receivable | -34 | -72 | -92 | 633 | 1,002 |
| Accounts payable and accrued liabilities | 586 | 236 | 188 | 866 | -1,883 |
| Other Working Capital | 596 | 133 | 260 | 1,695 | -572 |
| Other Operating Activity | -1,729 | -1,083 | -1,132 | -2,477 | -995 |
| Operating Cash Flow | $-529 | $-735 | $-725 | $856 | $-2,289 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | 12 | N/A | N/A |
| Other Investing Activity | 0 | -5 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $-5 | $12 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | -20 | -1,350 | 1,350 | -150 |
| Debt Repayment | -20 | -21 | 1,330 | -1,362 | -110 |
| Financing Cash Flow | $-20 | $-41 | $-19 | $-13 | $-259 |
| Beginning Cash Position | 806 | 1,588 | 2,320 | 1,723 | 4,272 |
| End Cash Position | 257 | 806 | 1,588 | 2,320 | 1,723 |
| Net Cash Flow | $-549 | $-782 | $-733 | $597 | $-2,548 |
| Free Cash Flow | |||||
| Operating Cash Flow | -529 | -735 | -725 | 856 | -2,289 |
| Free Cash Flow | -529 | -735 | -725 | 856 | -2,289 |